Comanche Biopharma

Comanche Biopharma company information, Employees & Contact Information

Comanche is a biopharmaceutical company developing an investigational siRNA medicine for preterm preeclampsia. We envision a world where all women and their babies have access to safe and effective therapies for treating life threatening complications of pregnancy, and those solutions must be evidence-based and affordable.

Company Details

Employees
25
Founded
-
Address
Concord, Massachusetts 01742, Us
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
Keywords
Walnut Creek.
HQ
Concord, Massachusetts
Looking for a particular Comanche Biopharma employee's phone or email?

Comanche Biopharma Questions

News

Comanche Biopharma raises $75M to fund preeclampsia drug testing - BioPharma Dive

Comanche Biopharma raises $75M to fund preeclampsia drug testing BioPharma Dive

Comanche Biopharma Strengthens Board of Directors with Appointment of Dr. Ann Taylor - PR Newswire

Comanche Biopharma Strengthens Board of Directors with Appointment of Dr. Ann Taylor PR Newswire

Foley Represents NEA as Lead Investor in Comanche Biopharma Series B Round - Foley & Lardner LLP

Foley Represents NEA as Lead Investor in Comanche Biopharma Series B Round Foley & Lardner LLP

Comanche Biopharma Appoints Allison August, M.D., As Chief Medical Officer - citybiz

Comanche Biopharma Appoints Allison August, M.D., As Chief Medical Officer citybiz

Comanche Biopharma Named by Fierce Biotech as a "Fierce 15" Biotech Company of 2023 - PR Newswire

Comanche Biopharma Named by Fierce Biotech as a "Fierce 15" Biotech Company of 2023 PR Newswire

80+ Pharma Companies Unite to Shape the Future of RNA-Based Therapeutics | DelveInsight - GlobeNewswire

80+ Pharma Companies Unite to Shape the Future of RNA-Based Therapeutics | DelveInsight GlobeNewswire

Comanche Biopharma Receives US FDA Fast Track Designation for CBP-4888 for the Treatment of sFlt-1 mediated pre-term preeclampsia - PR Newswire

Comanche Biopharma Receives US FDA Fast Track Designation for CBP-4888 for the Treatment of sFlt-1 mediated pre-term preeclampsia PR Newswire

Top Comanche Biopharma Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant